International Society for the Study of Women's Sexual Health

NEWS

FDA announced a Public Advisory Committee Meeting

FDA announced a Public Advisory Committee Meeting to review the approval of flibanserin for hypoactive sexual desire disorder (HSDD) in women on June 4, 2015. Should you wish to submit your written comments or request time at the public microphone, the deadline is a week away. Please find all details in the Federal Register Notice by clicking on this link. - -

Save the Date


ISSWSH Annual Meeting 2017

  February 23-26, 2017  1 days left
  Grand Hyatt Atlanta, Atlanta, GA - USA
Read more...


ISSWSH Fall Course 2017

  November 2-5, 2017  253 days left
  DoubleTree Hilton Hotel, Scottsdale, AZ - USA
Read more...

Latest Tweets

Partners of men w/prostate cancer may report even more distress about diagnosis than patient himself https://t.co/M4jQugBqJr ISSWSH
Stephen Porges will reveal how female sexual function emerges from nuanced nervous system changes with stress & ill… https://t.co/YIcyXMmh3t ISSWSH
The Program for the ISSWSH 2017 Annual Meeting is available! https://t.co/lFkSxJg2La https://t.co/YQepamiiYq ISSWSH

Contact Details

ISSWSH Executive Office
PO Box 1233
Lakeville, MN 55044
USA

Phone: +1 (952) 683 9025
Fax: +1 (612) 808 0491
Email: This email address is being protected from spambots. You need JavaScript enabled to view it.